Treatment of May-Thurner's Syndrome and Associated Complications: A Multicenter Experience.
May–Thurner syndrome
anticoagulation
complications
diagnosis
treatment
Journal
International journal of general medicine
ISSN: 1178-7074
Titre abrégé: Int J Gen Med
Pays: New Zealand
ID NLM: 101515487
Informations de publication
Date de publication:
2021
2021
Historique:
received:
20
06
2021
accepted:
02
08
2021
entrez:
27
8
2021
pubmed:
28
8
2021
medline:
28
8
2021
Statut:
epublish
Résumé
To assess the treatment options and associated complications in patients with May-Thurner's syndrome (MTS). We retrospectively reviewed the charts of patients diagnosed with MTS. Thorough review was completed and data relevant to methods of diagnosis, treatment, complications, hospital readmission, and mortality were extracted from patient charts. The patients were followed for two years after diagnosis. Of the 47 patients identified as having "MTS", 32 (70%) were diagnosed formally with either magnetic resonance venography, computed tomography venography, or ultrasound. Two patients were excluded for insufficient availability of follow-up records. Mean age of the population included (N = 30) was 50.24 ±15.33 years and 83% (N = 25) had female gender. The majority (40%) of patients were treated with anticoagulation, thrombolysis, and stent placement, and 13.3% received a combination of anticoagulation, antiplatelet agent, thrombolysis, and stent placement. Overall, we found 28 patients (93%) who underwent endovascular stenting. However, 39.3% (11/28) had stent-related complications that included stent thrombosis, stenosis, and migration. One patient underwent open heart surgery for stent retrieval. Duration of anticoagulation therapy ranged from 6 months to lifelong. Two patients (6.7%) suffered major bleeds requiring transfusion. Fourteen patients (46.6%) developed post-thrombotic syndrome. Seven (23.3%) patients required MTS-related readmission within 30 days. No mortality was noted at two-year follow-up. Although our study only included 30 patients, it was evident to us that there is no consensus in the management of MTS. Furthermore, endovascular stenting, which has a major role in the management of MTS, has complication rates that hover close to 40%. Further research is needed to help develop a standardized evidence-based approach in the management of MTS that ensures a decreased risk of immediate and long-term complications.
Identifiants
pubmed: 34447265
doi: 10.2147/IJGM.S325231
pii: 325231
pmc: PMC8384425
doi:
Types de publication
Journal Article
Langues
eng
Pagination
4705-4710Informations de copyright
© 2021 Sigua-Arce et al.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest regarding this work or the publication of this paper.
Références
Chest. 2016 Feb;149(2):315-352
pubmed: 26867832
Ann Surg. 2004 Jan;239(1):118-26
pubmed: 14685109
Ann Vasc Surg. 2016 Jul;34:144-51
pubmed: 27177710
J Vasc Surg. 2011 May;53(5):1303-8
pubmed: 21215568
Perspect Vasc Surg Endovasc Ther. 2010 Dec;22(4):223-30
pubmed: 21411461
Circulation. 2019 Feb 26;139(9):1162-1173
pubmed: 30586751
Proc (Bayl Univ Med Cent). 2012 Jul;25(3):231-3
pubmed: 22754121
J Vasc Surg. 2004 May;39(5):937-43
pubmed: 15111841
Case Rep Vasc Med. 2013;2013:740182
pubmed: 23509664
Angiology. 1957 Oct;8(5):419-27
pubmed: 13478912
Eur J Radiol. 2008 Dec;68(3):487-92
pubmed: 17900842
J Vasc Surg. 2009 Mar;49(3):697-703
pubmed: 19135831
J Endovasc Ther. 2009 Aug;16(4):483-91
pubmed: 19702343
Cochrane Database Syst Rev. 2016 Nov 10;11:CD002783
pubmed: 27830895
Vascular. 2009 Nov-Dec;17(6):330-5
pubmed: 19909680
J Vasc Surg Venous Lymphat Disord. 2014 Jan;2(1):107
pubmed: 26992988
J Thromb Haemost. 2009 May;7(5):879-83
pubmed: 19175497
J Investig Med High Impact Case Rep. 2018 Sep 07;6:2324709618799118
pubmed: 30211244
J Vasc Interv Radiol. 2013 Jan;24(1):17-24; quiz 26
pubmed: 23176966
Cardiovasc Diagn Ther. 2017 Dec;7(Suppl 3):S159-S164
pubmed: 29399519
J Vasc Surg. 2007 Nov;46(5):979-990
pubmed: 17980284
J Endovasc Ther. 2012 Apr;19(2):273-80
pubmed: 22545895
Case Rep Vasc Med. 2019 Mar 5;2019:7606727
pubmed: 30956838
Lancet. 2012 Jan 7;379(9810):31-8
pubmed: 22172244
J Vasc Interv Radiol. 2000 Jul-Aug;11(7):823-36
pubmed: 10928517
Radiologia. 2008 May-Jun;50(3):245-7
pubmed: 18471392
J Thromb Haemost. 2008 Jul;6(7):1105-12
pubmed: 18466316
J Vasc Surg. 1998 Sep;28(3):492-7
pubmed: 9737459
Catheter Cardiovasc Interv. 2010 Sep 1;76(3):316-25
pubmed: 20578224
Vasc Med. 2015 Feb;20(1):74-83
pubmed: 25502563
Chest. 2012 Feb;141(2 Suppl):e419S-e496S
pubmed: 22315268
Vasc Endovascular Surg. 2017 Apr;51(3):155-168
pubmed: 28330436
J Vasc Surg. 2011 Mar;53(3):706-12
pubmed: 21129907
Medicine (Baltimore). 2016 Jan;95(4):e2541
pubmed: 26825895
N Engl J Med. 2017 Dec 7;377(23):2240-2252
pubmed: 29211671
J Thromb Haemost. 2010 Sep;8(9):2083-4
pubmed: 20586917
Innovations (Phila). 2017 Nov/Dec;12(6):466-471
pubmed: 29049090
Eur J Vasc Endovasc Surg. 2002 Sep;24(3):209-14
pubmed: 12217281